Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole in the luteal phase after controlled ovarian stimulation in oocyte donors
2022-502586-21-00Phase 3Completed
- Sponsor
- IVI Madrid
- Start
- Mar 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of letrozole in female infertility (2 arms), sponsored by IVI Madrid. Primary endpoint: ovarian volume. Started Mar 2023; status: completed.
02
Drugs
letrozole
03
Conditions
female infertility
Beyond the preview
Go deeper on 2022-502586-21-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-502586-21-00.